| NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity T Moriyama, R Nishii, V Perez-Andreu, W Yang, FA Klussmann, X Zhao, ... Nature genetics 48 (4), 367-373, 2016 | 463 | 2016 |
| Association of an inherited genetic variant with vincristine-related peripheral neuropathy in children with acute lymphoblastic leukemia B Diouf, KR Crews, G Lew, D Pei, C Cheng, J Bao, JJ Zheng, W Yang, ... Jama 313 (8), 815-823, 2015 | 290 | 2015 |
| NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells SW Paugh, EJ Bonten, D Savic, LB Ramsey, WE Thierfelder, P Gurung, ... Nature genetics 47 (6), 607-614, 2015 | 157 | 2015 |
| The metastasis suppressor NM23-H1 possesses 3′-5′ exonuclease activity D Ma, JR McCorkle, DM Kaetzel Journal of Biological Chemistry 279 (17), 18073-18084, 2004 | 149 | 2004 |
| Metastasis suppressor function of NM23‐H1 requires its 3′‐5′ exonuclease activity Q Zhang, JR McCorkle, M Novak, M Yang, DM Kaetzel International journal of cancer 128 (1), 40-50, 2011 | 94 | 2011 |
| PACSIN2 polymorphism influences TPMT activity and mercaptopurine-related gastrointestinal toxicity G Stocco, W Yang, KR Crews, WE Thierfelder, G Decorti, M Londero, ... Human molecular genetics 21 (21), 4793-4804, 2012 | 75 | 2012 |
| Potential roles of 3′-5′ exonuclease activity of NM23-H1 in DNA repair and malignant progression DM Kaetzel, Q Zhang, M Yang, JR McCorkle, D Ma, RJ Craven Journal of bioenergetics and biomembranes 38, 163-167, 2006 | 67 | 2006 |
| The metastasis suppressor NME1 regulates expression of genes linked to metastasis and patient outcome in melanoma and breast carcinoma JR Mccorkle, MK Leonard, SD Kraner, EM Blalock, D Ma, SG Zimmer, ... Cancer genomics & proteomics 11 (4), 175-194, 2014 | 59 | 2014 |
| Integrative genomic analyses reveal mechanisms of glucocorticoid resistance in acute lymphoblastic leukemia RJ Autry, SW Paugh, R Carter, L Shi, J Liu, DC Ferguson, CE Lau, ... Nature cancer 1 (3), 329-344, 2020 | 53 | 2020 |
| c-Abl and Arg induce cathepsin-mediated lysosomal degradation of the NM23-H1 metastasis suppressor in invasive cancer LS Fiore, SS Ganguly, J Sledziona, ML Cibull, C Wang, DL Richards, ... Oncogene 33 (36), 4508-4520, 2014 | 49 | 2014 |
| Cancer pharmacogenomics SW Paugh, G Stocco, JR McCorkle, B Diouf, KR Crews, WE Evans Clinical Pharmacology & Therapeutics 90 (3), 461-466, 2011 | 48 | 2011 |
| Olaparib Combined with an ATR or Chk1 Inhibitor as a Treatment Strategy for Acquired Olaparib-Resistant BRCA1 Mutant Ovarian Cells BT Burgess, AM Anderson, JR McCorkle, J Wu, FR Ueland, JM Kolesar Diagnostics 10 (2), 121, 2020 | 37 | 2020 |
| Genetics of ancestry-specific risk for relapse in acute lymphoblastic leukemia SE Karol, E Larsen, C Cheng, X Cao, W Yang, LB Ramsey, ... Leukemia 31 (6), 1325-1332, 2017 | 31 | 2017 |
| Macrophage-engineered vesicles for therapeutic delivery and bidirectional reprogramming of immune cell polarization KR Neupane, JR McCorkle, TJ Kopper, JE Lakes, SP Aryal, M Abdullah, ... ACS omega 6 (5), 3847-3857, 2021 | 25 | 2021 |
| Cell-derived vesicles for in vitro and in vivo targeted therapeutic delivery AA Snell, KR Neupane, JR McCorkle, X Fu, FH Moonschi, EB Caudill, ... Acs Omega 4 (7), 12657-12664, 2019 | 23 | 2019 |
| Potential contributions of antimutator activity to the metastasis suppressor function of NM23-H1 DM Kaetzel, JR McCorkle, M Novak, M Yang, SG Jarrett Molecular and cellular biochemistry 329, 161-165, 2009 | 22 | 2009 |
| Pharmacogenomics of intracellular methotrexate polyglutamates in patients’ leukemia cells in vivo E Lopez-Lopez, RJ Autry, C Smith, W Yang, SW Paugh, JC Panetta, ... The Journal of Clinical Investigation 130 (12), 6600-6615, 2020 | 21 | 2020 |
| Multiple mechanisms underlie metastasis suppressor function of NM23-H1 in melanoma M Novak, SG Jarrett, JR McCorkle, I Mellon, DM Kaetzel Naunyn-Schmiedeberg's archives of pharmacology 384, 433-438, 2011 | 21 | 2011 |
| Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid‐resistant from glucocorticoid‐sensitive idiopathic nephrotic syndrome patients M Lucafò, S Granata, EJ Bonten, R McCorkle, G Stocco, C Caletti, ... Clinical and translational science 14 (3), 964-975, 2021 | 19 | 2021 |
| Lapatinib and poziotinib overcome ABCB1-mediated paclitaxel resistance in ovarian cancer JR McCorkle, JW Gorski, J Liu, MKB Riggs, AB McDowell, N Lin, C Wang, ... PLoS One 16 (8), e0254205, 2021 | 18 | 2021 |
